Compounds > 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide
Page last updated: 2024-09-03

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and tyrosine

4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with tyrosine in 1 studies

Compound Research Comparison

Studies
(4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide)		Trials
(4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide)		Recent Studies (post-2010)
(4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide)		Studies
(tyrosine)		Trials
(tyrosine)		Recent Studies (post-2010) (tyrosine)
27908544,2738468,225

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, W; Butterworth, J; Labarre, M; McClory, A; Mischki, T; Pagé, D; Payza, K; Schmidt, R; St-Onge, S1

Other Studies

1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and tyrosine

ArticleYear
Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2000, Jan-17, Volume: 10, Issue:2

    Topics: Benzamides; Binding, Competitive; Dipeptides; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Isoquinolines; Piperazines; Receptors, Opioid, delta; Tetrahydroisoquinolines; Tyrosine

2000